Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: Results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation

被引:83
作者
Kitchen, Steve [1 ]
Jennings, Ion [1 ]
Woods, Tim A. L. [1 ]
Kitchen, Dianne P. [1 ]
Walker, Isobel D. [1 ]
Preston, Francis E. [1 ]
机构
[1] United Kingdom Natl External Qual Assessment Sche, Sheffield, S Yorkshire, England
关键词
von Willebrand factor : antigen (VWF : Ag); von Willebrand factor : ristocetin cofactor activity (vWF : RCo); laboratory assays; von Willebrand disease (vWD);
D O I
10.1055/s-2006-947863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recognition of the importance of von Willebrand factor (vWF) testing in the diagnosis of von Willebrand disease (vWD), the United Kingdom National External Quality Assessment Scheme for Blood Coagulation regularly distributes samples for determination of v W:antigen (vWF:Ag). Data from 10 separate surveys performed between 2001 and 2005 are reviewed. These include results from similar to 200 different centers, of which 55% are within the United Kingdom and the remainder are from other countries. During the period of the surveys, the use of immunoelectrophoresis for determination of vWF:Ag practically disappeared and was largely replaced by latex agglutination assays. The coefficient of variation (CV) of results in different centers was similar to 15 to 20% for most vWF:Ag techniques, with CVs of similar to 7% for a fluorescence-based assay. Several different techniques were used for determination of vWF ristocetin cofactor activity (vWF:RCo), all of which were associated with poor agreement among centers as indicated by CVs of 40 to 50%. Several centers calculated the ratio of vWF:Ag/vWF:RCo but with variable success. Ratios compatible with either type 1 or type 2 vWD were obtained on samples from subjects with type 1 vWD, as well as on samples from subjects with genetically confirmed type 2 vWD. Overall, our data show that laboratory testing for vWD remains problematic. It remains to be seen whether newer techniques will offer consistently improved precision.
引用
收藏
页码:492 / 498
页数:7
相关论文
共 17 条
  • [1] Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
    Allen, S
    Abuzenadah, AM
    Blagg, JL
    Hinks, J
    Nesbitt, IM
    Goodeve, AC
    Gursel, T
    Ingerslev, J
    Peake, IR
    Daly, ME
    [J]. BLOOD, 2000, 95 (06) : 2000 - 2007
  • [2] Castaman G, 2003, HAEMATOLOGICA, V88, P94
  • [3] CREAGMILE SD, 1999, THROMB HAEMOST
  • [4] Laboratory diagnosis of von Willebrand disorder - Current practice in the Southern Hemisphere
    Favaloro, EJ
    Bonar, R
    Sioufi, J
    Hertzberg, M
    Street, A
    Lloyd, J
    Marsden, K
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (06) : 882 - 893
  • [5] von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: A 15-year journey
    Favaloro, EJ
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02) : 191 - 202
  • [6] Favaloro Emmanuel J, 2005, Lab Hematol, V11, P91, DOI 10.1532/LH96.04063
  • [7] Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
    Federici, AB
    Mazurier, C
    Berntorp, E
    Lee, CA
    Scharrer, I
    Goudemand, J
    Lethagen, S
    Nitu, I
    Ludwig, G
    Hilbert, L
    Mannucci, PM
    [J]. BLOOD, 2004, 103 (06) : 2032 - 2038
  • [8] Federici AB, 2000, THROMB HAEMOSTASIS, V84, P1127
  • [9] Laboratory performance of haemophilia centres in developing countries: 3 years' experience of the World Federation of Hemophilia External Quality Assessment Scheme
    Jennings, I
    Kitchen, S
    Woods, TAL
    Preston, FE
    [J]. HAEMOPHILIA, 1998, 4 (05) : 739 - 746
  • [10] The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization
    Laffan, M
    Brown, SA
    Collins, PW
    Cumming, AM
    Hill, FGH
    Keeling, D
    Peake, IR
    Pasi, KJ
    [J]. HAEMOPHILIA, 2004, 10 (03) : 199 - 217